These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 15267226)

  • 21. [Current views on the mechanism of photodynamic therapy. Photosensitizers and their bioavailability].
    Iagudaev DM; Sorokatyĭ AE; Geĭnits AV; Trukhmanov RS
    Urologiia; 2006; (5):94-8. PubMed ID: 17444162
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis of 2-morpholinetetraphenylporphyrins and their photodynamic activities.
    Liao PY; Wang XR; Zhang XH; Hu TS; Zheng MZ; Gao YH; Yan YJ; Chen ZL
    Bioorg Chem; 2017 Apr; 71():299-304. PubMed ID: 28267982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diketopyrrolopyrrole-porphyrin conjugates with high two-photon absorption and singlet oxygen generation for two-photon photodynamic therapy.
    Schmitt J; Heitz V; Sour A; Bolze F; Ftouni H; Nicoud JF; Flamigni L; Ventura B
    Angew Chem Int Ed Engl; 2015 Jan; 54(1):169-73. PubMed ID: 25370127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phthalocyanine-based photosensitizers: more efficient photodynamic therapy?
    Ng DK
    Future Med Chem; 2014; 6(18):1991-3. PubMed ID: 25531964
    [No Abstract]   [Full Text] [Related]  

  • 25. Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy.
    Pandey RK; Goswami LN; Chen Y; Gryshuk A; Missert JR; Oseroff A; Dougherty TJ
    Lasers Surg Med; 2006 Jun; 38(5):445-67. PubMed ID: 16788930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new protocol in photodynamic therapy: enhanced tumour cell death by combining two different photosensitizers.
    Villanueva A; Stockert JC; Cañete M; Acedo P
    Photochem Photobiol Sci; 2010 Mar; 9(3):295-7. PubMed ID: 20221454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential use of biodegradable nanoparticles for the photodynamic therapy of eye diseases.
    Vargas A; Delie F
    Arch Soc Esp Oftalmol; 2009 Apr; 84(4):169-71, 173-5. PubMed ID: 19384755
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-macular degeneration agents.
    Rothen M; Jablon E; Monares G; Fontal MR; Alfaro DV
    Ophthalmol Clin North Am; 2005 Dec; 18(4):561-7. PubMed ID: 16314219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of liposomal porphyrinoid photosensitizers.
    Skupin-Mrugalska P; Piskorz J; Goslinski T; Mielcarek J; Konopka K; Düzgüneş N
    Drug Discov Today; 2013 Aug; 18(15-16):776-84. PubMed ID: 23591149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photodynamic therapy for AMD: smaller is better!
    la Cour M
    Acta Ophthalmol Scand; 2004 Dec; 82(6):641-2. PubMed ID: 15606456
    [No Abstract]   [Full Text] [Related]  

  • 31. Photodynamic efficiency of diethylene glycol-linked glycoconjugated porphyrins in human retinoblastoma cells.
    Laville I; Pigaglio S; Blais JC; Doz F; Loock B; Maillard P; Grierson DS; Blais J
    J Med Chem; 2006 Apr; 49(8):2558-67. PubMed ID: 16610799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between 5,10,15,20-tetraaryl- and 5,15-diarylporphyrins as photosensitizers: synthesis, photodynamic activity, and quantitative structure-activity relationship modeling.
    Banfi S; Caruso E; Buccafurni L; Murano R; Monti E; Gariboldi M; Papa E; Gramatica P
    J Med Chem; 2006 Jun; 49(11):3293-304. PubMed ID: 16722648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment.
    Busch T
    Retina; 2009 Jun; 29(6 Suppl):S36-8. PubMed ID: 19553798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New treatment for macular degeneration being tested.
    Mayo Clin Health Lett; 2000 Feb; 18(2):4. PubMed ID: 10870461
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of novel long wavelength cationic chlorins via stereoselective aldol-like condensation.
    Li JZ; Wang JJ; Yoon I; Cui BC; Shim YK
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1846-9. PubMed ID: 22335896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.
    Frochot C; Di Stasio B; Vanderesse R; Belgy MJ; Dodeller M; Guillemin F; Viriot ML; Barberi-Heyob M
    Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive tumor suppression by anti-angiogenic photodynamic therapy with polycation-modified liposomal photosensitizer.
    Takeuchi Y; Kurohane K; Nango M; Oku N
    Cell Mol Biol Lett; 2002; 7(2):301. PubMed ID: 12097971
    [No Abstract]   [Full Text] [Related]  

  • 38. Photodynamic therapy using a novel photosensitizer, EC036, is more effective compared with ATX-S10(Na) photodynamic therapy.
    Takahashi H; Nakajima S; Asano R; Nakae Y; Sakata I; Iizuka H
    J Dermatol Sci; 2009 Aug; 55(2):130-2. PubMed ID: 19398306
    [No Abstract]   [Full Text] [Related]  

  • 39. Vision repaired.
    Kipp A
    J Dent Hyg; 2000; 74(2):86. PubMed ID: 11314059
    [No Abstract]   [Full Text] [Related]  

  • 40. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
    Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T
    Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.